M

Moleculin Biotech
D

MBRX

2.68500
USD
-0.05
(-1.65%)
Market Closed
Volume
0
EPS
-8
Div Yield
-
P/E
-0
Market Cap
8,060,088
OverviewSignalsIdeasNews
Related Instruments
    A
    AGEN
    -0.05000
    (-1.80%)
    2.72500 USD
    A
    ALT
    -0.85500
    (-10.11%)
    7.60000 USD
    A
    APVO
    -0.03000
    (-12.49%)
    0.21010 USD
    A
    ASUR
    0.01000
    (0.12%)
    8.68000 USD
    B
    BNGO
    -0.00920
    (-3.60%)
    0.24620 USD
    C
    CYCC
    -0.01820
    (-4.69%)
    0.36990 USD
    E
    EVOK
    0.06000
    (1.36%)
    4.46000 USD
    O
    OCUL
    -0.77000
    (-7.75%)
    9.16000 USD
    P
    PGEN
    -0.05970
    (-6.79%)
    0.82010 USD
    T
    TNXP
    -0.00910
    (-6.53%)
    0.13030 USD
    More
News

Title: Moleculin Biotech

Sector: Healthcare
Industry: Biotechnology
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.